📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-17 13:50
0 analysed today
FollowTelegram
0
Today
151,853
All-time analysed
43,533
Positive
6,742
Negative
92,741
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
9 announcements match the current filters (relevance ≥ 5).
Indo Amines Suspends Mahad Plant Operations Following Fatal Gas Leak on Aug 15, 2026
Indo Amines reported an unfortunate gas leakage incident at its Mahad manufacturing facility (Raigad, Maharashtra) on August 15, 2026, resulting in two fatalities (one plant worker and one neighbouring unit worker). As a precautionary measure, operations at the Mahad plant have been temporarily suspended effective August 15, 2026, while statutory investigations and technical assessments are conducted. The exact duration of downtime and total financial/production loss are currently under assessment, though the plant is covered under insurance policies. The company, which generated TTM revenue of ₹1,240 Cr, is evaluating shifting customer orders to other manufacturing facilities to mitigate supply disruptions.
Confidence: HIGH
What changedIndo Amines has temporarily shut down its Mahad manufacturing facility following a fatal gas leakage incident on August 15, 2026.
Why it mattersUnscheduled plant shutdown can impact short-term specialty chemical production and order deliveries, while exposing the firm to potential statutory scrutiny and liabilities.
Date of incident: August 15, 2026Fatalities: 2Financial loss quantum: not disclosedCompany TTM revenue context: ₹1240 Cr
📅 Short termDisruption at the Mahad facility poses execution and delivery risks in the near term, with financial impact dependent on how quickly volumes can be redirected to other plants.
📈 Long termLong-term impact hinges on the findings of statutory authorities, safety compliance audits, and whether any extended closure or regulatory actions are mandated.
⚠ Risk flags
- Statutory inquiry and regulatory compliance risk
- Unquantified production downtime and dispatch delays
- Potential liability and remediation costs
Key Highlights
Gas leakage incident occurred on August 15, 2026, at the Mahad MIDC facility in Raigad, Maharashtra.
Tragic loss of 2 lives reported (1 employee at the plant and 1 person at an adjacent industrial unit).
Mahad plant operations temporarily suspended effective August 15, 2026, pending statutory investigation.
Quantum of financial damage, production loss, and restart timeline are currently not disclosed/under assessment.
Facility is covered under insurance policies, with recoverable amounts under assessment.
👀 What to Watch
Track upcoming regulatory disclosures regarding the statutory inquiry findings, potential compliance penalties, and the confirmed timeline for restarting Mahad plant operations.
Indo Amines Approves Q1 FY27 Results; TTM Revenue Stands at ₹1,160 Cr
Indo Amines approved its unaudited financial results for the quarter ended June 30, 2026, in a board meeting held on August 12, 2026. The company enters the new fiscal year following a strong FY26 where revenue reached ₹1,160 Cr and PAT grew to ₹80 Cr. Investors should monitor the detailed P&L for margin stability, as raw materials constitute 68% of revenue. The company continues to invest in growth, evidenced by a Capital Work in Progress (CWIP) of ₹61.71 Cr.
Confidence: MEDIUM
What changedThe company has formally approved and released its financial performance data for the first quarter of the 2026-27 fiscal year.
Why it mattersAs a specialty chemical player targeting 15% growth, these results provide the first benchmark for FY27 performance and the integration of recent acquisitions like Indo Specialty Chemicals.
TTM Revenue: ₹1160 CrTTM PAT: ₹80 CrCWIP vs Net Worth: ~15.8%Debt-to-Equity: 0.78ROCE: 20.0%
📅 Short termThe stock may see neutral to range-bound movement until the specific quarterly growth figures are compared against the ₹28.84 Cr PAT from Jun 2025.
📈 Long termStructural growth is tied to the successful utilization of the ₹61.71 Cr CWIP and expansion into global markets via subsidiaries in the USA and Europe.
⚠ Risk flags
- Raw material price sensitivity (68% of revenue)
- Dependency on commodity price cycles
- Trade barriers in international subsidiary regions
Key Highlights
Board approved financial results for the quarter ended June 30, 2026, on August 12, 2026.
TTM Revenue for the period ending March 2026 was ₹1,160 Cr with a PAT of ₹80 Cr.
Capital Work in Progress (CWIP) of ₹61.71 Cr indicates ongoing capacity expansion projects.
Raw material costs represent approximately 68% of total revenue, making margins sensitive to input prices.
Promoter holding remains stable at 58.42% as of the latest reporting period.
👀 What to Watch
Monitor the detailed quarterly filing for the specific operating profit margin (OPM) to see if it maintains the 10.56% level achieved in FY26 despite commodity price fluctuations.
GPCB Revokes Closure Order for Indo Amines' Vadodara Plant for 3 Months
Indo Amines has received a revocation order from the Gujarat Pollution Control Board (GPCB) for its manufacturing plant in Vadodara, which was previously issued a closure notice on July 21, 2026. The revocation is valid for a period of three months, allowing the company to resume operations subject to specific compliance conditions. The company has paid ₹5.70 lakh as environmental compensation and submitted a ₹5.00 lakh bank guarantee. This resolution allows the company to restore production capacity that was halted for approximately three weeks.
Confidence: HIGH
What changedThe Vadodara manufacturing facility, which was shut down due to GPCB directions in July 2026, is now permitted to resume operations.
Why it mattersThe resumption of the Vadodara plant prevents further revenue loss and ensures the company can utilize its capacity to meet its 15% growth target. The financial penalty of ₹5.70 lakh is negligible compared to the TTM revenue of ₹1160 Cr.
Environment Damage Compensation: ₹5.70 lakhBank Guarantee: ₹5.00 lakhRevocation Period: 3 monthsTTM Revenue: ₹1160 Cr
📅 Short termThe resumption of operations is a positive development that removes the immediate operational bottleneck and uncertainty surrounding the Vadodara unit.
📈 Long termLimited structural impact, provided the company maintains environmental compliance to avoid recurring regulatory friction.
⚠ Risk flags
- Conditional revocation (3 months only)
- Regulatory compliance risk
Key Highlights
Revocation order received on August 11, 2026, following a closure direction issued on July 21, 2026
Revocation is granted for a temporary period of 3 months subject to compliance with GPCB conditions
Paid ₹5.70 lakh as interim Environment Damage Compensation to the GPCB
Submitted a bank guarantee of ₹5.00 lakh valid until September 30, 2027
Corrective measures were verified during a GPCB inspection conducted on July 31, 2026
👀 What to Watch
Investors should monitor the company's ability to secure a permanent revocation after the 3-month conditional period and watch for any impact on quarterly margins due to compliance costs.
GPCB Issues Closure Order for Indo Amines' Vadodara Plant Due to Environmental Non-Compliance
Indo Amines has received a closure directive from the Gujarat Pollution Control Board (GPCB) for its manufacturing facility in Vadodara. The order follows an inspection on July 13, 2026, which identified non-compliances with the Water and Air Acts. The closure is mandated to take effect 15 days from the issuance date of July 21, 2026. While the company is seeking revocation through corrective measures and other units remain operational, the specific revenue contribution of this plant is not disclosed, creating uncertainty regarding the impact on its Rs 1,160 Cr TTM revenue.
Confidence: HIGH
What changedThe Gujarat Pollution Control Board has ordered the mandatory shutdown of a key manufacturing site in Vadodara due to environmental violations.
Why it mattersRegulatory shutdowns can lead to immediate revenue loss and supply chain disruptions, potentially impacting the company's 10.6% operating margins and overall growth targets.
Inspection Date: July 13, 2026Closure Effective Period: 15 days from issuanceTTM Revenue: Rs 1,160 CrMarket Cap: Rs 929 CrDebt to Equity: 0.78
📅 Short termThe stock is likely to face downward pressure as investors price in the risk of production halts and potential remediation costs at the Vadodara site.
📈 Long termIf the closure is prolonged, it could hinder the company's 15% expected growth rate; however, a swift resolution through compliance would limit structural damage.
⚠ Risk flags
- Regulatory non-compliance
- Operational disruption
- Environmental litigation risk
Key Highlights
Closure order issued under Section 33A of the Water Act and Section 31A of the Air Act following a July 13, 2026 inspection.
Manufacturing operations at Plot Nos. 1723, 1724, and 1746 in Tundav, Vadodara, must cease within 15 days of the order.
The company is in the process of submitting a response to GPCB to obtain a revocation of the closure directions.
Manufacturing activities at all other units of the company remain operational as of the announcement date.
Indo Amines reported a TTM revenue of Rs 1,160 Cr and a PAT of Rs 80 Cr prior to this regulatory action.
👀 What to Watch
Watch for follow-up disclosures regarding the successful revocation of the closure order and any quantification of production loss or financial impact from the Vadodara facility.
Indo Amines Proposes Remuneration Hikes and Director Re-appointment via Postal Ballot
Indo Amines Limited has initiated a postal ballot to seek shareholder approval for several key management decisions. The primary resolutions include the re-appointment of Mrs. Bharati Palkar as Whole-Time Director for a three-year term and a proposed increase in remuneration for MD & CEO Mr. Vijay Palkar to a ceiling of ₹3.00 crore per annum for FY 2026-27. Additionally, the company is seeking to increase the compensation for Joint MD Mr. Rahul Vijay Palkar and Whole-Time Director Mr. Saji Jose. The e-voting process will conclude on July 15, 2026, with results expected by July 17, 2026.
Key Highlights
Re-appointment of Mrs. Bharati Palkar as Whole-Time Director for a 3-year term effective July 20, 2026.
Proposed remuneration for MD & CEO Mr. Vijay Palkar capped at ₹3.00 crore per annum for the period April 1, 2026, to March 31, 2027.
Remuneration increases proposed for Joint MD Mr. Rahul Vijay Palkar and Whole-Time Director Mr. Saji Jose.
Remote e-voting period scheduled from June 16, 2026, to July 15, 2026.
Results of the postal ballot to be announced on or before July 17, 2026.
👀 What to Watch
Investors should review the explanatory statement to ensure the proposed remuneration hikes are justified by the company's financial performance and growth trajectory. No immediate action is required other than participating in the e-voting process.
Indo Amines Approves 5.6 Lakh ESOPs at Rs 10 and Recommends 10% Final Dividend
Indo Amines Limited has announced a final dividend of Rs. 0.50 per share (10% of face value) for the financial year ended March 31, 2026. The company also approved the grant of 5,60,000 stock options under its ESOP 2025 plan at an exercise price of Rs. 10 per share. These options follow a five-year vesting schedule, which aims to retain key talent and align employee interests with shareholders. Additionally, the board confirmed the re-appointment of Mrs. Bharati Vijay Palkar as Whole-Time Director for a three-year term.
Key Highlights
Recommended a final dividend of 10% (Rs. 0.50 per equity share) on a face value of Rs. 5.
Granted 5,60,000 stock options to eligible employees at an exercise price of Rs. 10 per option.
ESOP vesting schedule is spread over 5 years: 10%, 15%, 20%, 25%, and 30% annually.
Re-appointed Mrs. Bharati Vijay Palkar as Whole-Time Director for 3 years effective July 20, 2026.
Approved audited standalone and consolidated financial results for the fiscal year ended March 31, 2026.
👀 What to Watch
Investors should benefit from the recommended dividend and may view the long-term ESOP vesting schedule as a positive sign for management stability. Review the full audited financial results to assess the company's growth trajectory in the specialty chemicals space.
Indo Amines FY26 Net Profit Jumps 30% to ₹79.77 Cr; Declares 10% Dividend
Indo Amines Limited reported a robust financial performance for the fiscal year ended March 31, 2026, with standalone revenue reaching ₹1,117.97 crore, up from ₹1,056.58 crore in the previous year. The annual net profit witnessed a significant growth of 29.9%, climbing to ₹79.77 crore compared to ₹61.40 crore in FY25. The fourth quarter was particularly strong, with net profit surging 89% year-on-year to ₹20.79 crore. Alongside the results, the board recommended a final dividend of ₹0.50 per share and approved the grant of 5.6 lakh ESOPs to eligible employees.
Key Highlights
Annual Standalone Revenue from Operations grew 5.8% YoY to ₹1,117.97 crore.
Full-year Net Profit increased by 29.9% to ₹79.77 crore from ₹61.40 crore in FY25.
Q4 FY26 Net Profit surged 89% YoY to ₹20.79 crore compared to ₹10.98 crore in Q4 FY25.
Board recommended a final dividend of 10% (₹0.50 per equity share of ₹5 face value).
Approved the grant of 5,60,000 Stock Options under the Employee Stock Option Plan 2025.
👀 What to Watch
The strong bottom-line growth and consistent dividend payout reflect healthy operational efficiency and a positive outlook. Investors should maintain a positive stance while monitoring the impact of the new ESOP plan on equity dilution.
Indo Amines Dilutes Stake in Indo Speciality Chemicals to 39.39%; Status Changes to Associate
Indo Amines Limited has announced a reduction in its shareholding in its subsidiary, Indo Speciality Chemicals Private Limited, from 51.39% to 39.39%. This dilution occurred because the company opted not to participate in the subsidiary's Rights Issue. As a result, the entity has been reclassified from a subsidiary to an Associate Company effective March 30, 2026. Management has stated that this change will not have a material impact on the overall operations of the company.
Key Highlights
Shareholding in Indo Speciality Chemicals reduced by 12% from 51.39% to 39.39%
Status of the entity changed from Subsidiary to Associate Company effective March 30, 2026
Dilution was caused by non-participation in the subsidiary's Rights Issue
Management confirms no material impact on overall business operations
👀 What to Watch
Investors should note the change in accounting treatment from consolidation to the equity method for this entity. Monitor for any strategic shifts in capital allocation that led to the decision not to maintain the majority stake.
Indo Amines Q3 Standalone Net Profit Drops 21% YoY to ₹12.86 Cr Despite Revenue Growth
Indo Amines reported a standalone revenue of ₹268.73 crore for Q3 FY26, a 4.8% increase compared to ₹256.45 crore in the same period last year. However, standalone net profit saw a significant decline of 21.2% YoY and 37.6% QoQ, falling to ₹12.86 crore. The profitability was impacted by rising operational expenses and employee benefit costs, leading to a contraction in net profit margins to 4.79% from 7.72% in the previous quarter. Despite the top-line growth, the sharp decline in margins and bottom-line performance presents a cautious outlook.
Key Highlights
Standalone Revenue from Operations grew 4.8% YoY to ₹268.73 crore from ₹256.45 crore.
Standalone Net Profit fell 21.2% YoY to ₹12.86 crore, down from ₹16.32 crore in the previous year's quarter.
Operating Margin contracted significantly to 10.26% in Q3 FY26 from 14.39% in Q2 FY26.
Earnings Per Share (EPS) declined to ₹1.76 from ₹2.24 in the corresponding quarter of the previous year.
Total expenses increased to ₹253.94 crore, with employee benefit expenses rising to ₹15.29 crore.
👀 What to Watch
Investors should exercise caution as the company is facing significant margin pressure despite maintaining revenue growth. It is advisable to monitor the management's strategy for cost control and margin recovery in the upcoming quarters.
